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Abstract: Studies on DNA from pathogenic organisms, within clinical samples, are often complicated by the presence of 
large amounts of host, e.g., human DNA. Isolation of pathogen DNA from these samples would improve the efficiency of 
next-generation sequencing (NGS) and pathogen identification. Here we describe a solution-based hybridisation method 
for isolation of pathogen DNA from a mixed population. This straightforward and inexpensive technique uses probes 
made from whole-genome DNA and off-the-shelf reagents.  
In this study, Escherichia coli DNA was successfully enriched from a mixture of E.coli and human DNA. After 
enrichment, genome coverage following NGS was significantly higher and the evenness of coverage and GC content were 
unaffected. This technique was also applied to samples containing a mixture of human and Plasmodium falciparum DNA. 
The P.falciparum genome is particularly difficult to sequence due to its high AT content (80.6%) and repetitive nature. 
Post enrichment, a bias in the recovered DNA was observed, with a poorer representation of the AT-rich non-coding 
regions. This uneven coverage was also observed in pre-enrichment samples, but to a lesser degree. Despite the coverage 
bias in enriched samples, SNP (single-nucleotide polymorphism) calling in coding regions was unaffected and the 
majority of samples had over 90% of their coding region covered at 5x depth. 
This technique shows significant promise as an effective method to enrich pathogen DNA from samples with heavy 
human contamination, particularly when applied to GC-neutral genomes. 
Keywords: AT-rich DNA, clinical samples, E.coli, enrichment, host DNA contamination, in-solution hybridisation, next 
generation sequencing, P.falciparum. 
INTRODUCTION 
 According to the World Health Organisation, infectious 
diseases are the world’s biggest killer of children and young 
people, causing 15 million deaths per year. If the causal 
pathogen can be identified, many of these diseases are 
treatable via vaccination and/or drug-treatment regimens. 
Point-of-care microbial or pathoclinical DNA sample 
collection for the identification of pathogens can be difficult, 
particularly in the developing world and during pathogenic  
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outbreaks. This means that clinical samples are often 
composed of a mixture of pathogen and host DNA. For 
example, when blood samples are taken for the detection of 
the malaria parasite Plasmodium, there is often significant 
contamination with human DNA. Although next-generation 
sequencing has the capacity to sequence all of the DNA 
contained within a clinical sample, this is very inefficient 
and increases the cost, computational burden and duration of 
the analyses. In addition, the human component is often 
preferentially sequenced because the methodologies are 
optimised for human DNA and this genome has a relatively 
neutral GC content. This neutrality makes the amplification 
and sequencing easier than for many pathogens that have 
extreme GC contents, for example the Plasmodium genome 
contains less than 20% GC bases [1].  
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 It would be beneficial to be able to isolate the pathogen 
DNA from the unwanted human contamination. This would 
ensure that only the DNA of interest is being sequenced, 
reducing the amount of sequencing required to obtain 
adequate coverage and depth and enable meaningful analysis 
of the data. The majority of studies rely upon growing 
pathogens in the laboratory, which is a time consuming 
approach, is not always successful and is subject to potential 
selective pressures. Commercial kits for the isolation of 
bacterial DNA from whole blood are available. The MolYsis 
kit from Molzym (www.molzym.com) works by lysing 
human cells under chaotropic conditions which do not affect 
bacterial cells due to their more rigid cell walls [2, 3]. The 
LOOXSTERTM method commercialised by SIRS-Lab 
(www.sirs-lab.de) isolates bacterial DNA based upon the 
presence of non-methylated CpG dinucleotides in the 
bacterial but not in the human DNA [2, 3]. Neither of these 
techniques will work for all pathogen types, because not all 
types of microbes have rigid cell walls or contain 
unmethylated CpG dinucleotides. Another method for 
separation of pathogen and host DNA utilises Hoechst dye 
and ultracentrifugation in a CsCl gradient; however, this will 
only isolate DNA with a significantly different GC content to 
the host [4]. The Hoechst dye method can be useful for the 
isolation of Plasmodium DNA, but has limited utility for 
other pathogens [4]. In addition, it requires large amounts of 
starting material and is both inefficient and low-throughput. 
Isolation of microbial cells from blood samples has also been 
carried out using various density gradients and magnetic 
isolation techniques [5-7]. 
 For sequencing-based studies, another approach to 
selectively isolate DNA would use oligonucleotide  
probes designed specifically against the pathogen under 
investigation. Many target-enrichment methods for next-
generation sequencing applications have been developed, 
including those commercialised by Agilent Technologies 
(www.genomics.agilent.com), Roche Nimblegen (www. 
nimblegen.com), RainDance Technologies (www.raindance 
technologies.com), Halo Genomics (www.halogenomics. 
com) and Illumina (www.illumina.com) [8-11]. The most 
widely used technique is Agilent’s SureSelect Target 
Enrichment System, which is a hybridisation-based sequence 
capture using a set of oligonucleotide capture probes, either 
in-solution or attached to a solid support [9]. Currently, the 
main use of these target-enrichment technologies is for 
human exome sequencing and targeted selection of regions 
of the human genome. However, it would also be possible to 
purchase a library of probes designed against any small 
genome of interest which could then be used to enrich 
clinical samples for that organism and help to eliminate 
human contamination. However, even for the isolation of 
small genomes this would be very costly.  
 In order to reduce the cost of target-enrichment 
techniques for the isolation of microbial DNA from clinical 
samples, we have developed a whole-genome pathogen 
capture technique. This technique is a solution-based target 
enrichment approach, similar to that used by Agilent,  
which utilises off-the-shelf reagents and home-made probes 
which can be made using whole-genome DNA from any 
organism of interest, exemplified in this study by E.coli  
or P.falciparum [9]. In this study, probes were made by 
fragmentation and biotinylation of whole-genome DNA from 
the organism of interest. A similar method was recently 
published by Melnikov et al., in Genome Biology [12] where 
home-made RNA baits were used. The DNA samples under 
investigation in our study were subjected to Illumina library 
preparation before denaturation at high temperature of both 
the library and probes and subsequent hybridisation together 
for 24 hours before isolation of the captured material using 
streptavidin-coated beads. The isolated DNA was then 
quantified by qPCR (quantitative polymerase chain reaction) 
and sequenced using next-generation sequencing technology 
(Illumina). As an alternative strategy, whole-genome human 
probes were produced utilising the same protocol and these 
were used to remove the human contamination from a mixed 
human/pathogen sample. A similar hybridisation technique 
to that described above was employed, collecting and 
sequencing the hybridisation eluate rather than the probe-
bound DNA. 
 The solution capture method developed in this study has 
applications for the identification of pathogens in clinical 
samples. Index tagging (multiplexing) of DNA samples 
would enable several patient samples to be hybridised and 
sequenced simultaneously. Alternatively, it should be 
possible to selectively target multiple pathogens in the same 
capture experiment, for example, for detection from 
metagenomic samples. Whole-genome solution capture has 
many potential clinical applications, as it offers a cost-
effective method to isolate pathogens from clinical samples. 
This allows the whole-genome sequencing of the isolated 
pathogens, opening up new opportunities in infectious-
disease control and prevention. 
 In this study, a whole-genome, solution-based 
hybridisation technique has been developed that can be used 
to isolate pathogen DNA from samples with high levels of 
human contamination. This technique was tested with E.coli 
and P.falciparum and was shown to provide enrichment of 
pathogen DNA in each case. This has the potential for 
clinical utility, especially for GC-neutral genomes. 
RESULTS AND DISCUSSION 
E.coli 
 Preliminary experiments were carried out to isolate E.coli 
DNA from mixed samples of E.coli and human DNA. E.coli 
was chosen because of the small size (~4.6Mb) and neutral 
GC content (50.8% GC) of its genome [13]. A range of 
mixtures were attempted including 10:90, 25:75 and 50:50 
E.coli:human DNA. In all cases, the proportion of E.coli 
DNA was significantly enriched after the pulldown 
procedure, with over 85% of the sequencing reads aligning 
to the E.coli genome after pulldown enrichment (Table 1, 
1A). The depth of coverage throughout the genome was 
significantly higher after enrichment, further demonstrating 
the utility of this technique (Table 2, 1A). The GC content 
and the evenness of coverage were comparable between  
the pre- and post-enrichment samples, showing that the 
enrichment procedure is not biased for this genome (Figs. 1A 
and 1C).  
 Further experiments were carried out to determine the 
optimum DNA requirements for probe synthesis and input 
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Table 1. Enrichment Statistics for the E.coli Genome Pre- and Post- solution-based Pulldown 
Experiment Sample ID Sample Name Probe Read Count % E.coli % Human % Other 
1A i E.coli:human 50:50 prepulldown ~ 10311001 36.04 26.66 37.30 
1A ii E.coli:human 25:75 prepulldown ~ 13668667 28.25 59.71 12.05 
1A iii E.coli:human 10:90 prepulldown ~ 17347896 10.53 69.99 19.48 
1A iv E.coli:human 50:50 pulldown E.coli 1.5µg 15067104 87.49 6.86 5.65 
1A v E.coli:human 25:75 pulldown E.coli 1.5µg 11206843 88.33 5.04 6.63 
1A 
1A vi E.coli:human 10:90 pulldown E.coli 1.5µg 11884992 85.03 9.08 5.89 
1B i E.coli:human 20:80 prepulldown ~ 12757413 9.30 38.32 52.37 
1B ii E.coli:human 20:80 800ng E.coli 3µg 20079543 79.85 5.31 14.84 
1B iii E.coli:human 20:80 1600ng E.coli 3µg 25326464 76.41 7.71 15.88 
1B iv E.coli:human 20:80 prepulldown ~ 38139698 9.47 55.42 35.11 
1B 
1B v E.coli:human 20:80 800ng E.coli 1.5µg 45334592 80.41 7.98 11.61 
3A i E.coli:human 20:80 prepulldown ~ 38139698 9.47 55.42 35.11 
3A ii E.coli:human 20:80 E.coli 1.5µg 45334592 80.41 7.98 11.61 
3A iii E.coli:human 20:80 human 10µg 38158190 4.47 72.26 23.27 
3A iv E.coli:human 20:80 eluate human 10µg 34334647 11.06 45.87 43.08 
3A v E.coli:human 20:80 eluate human 3µg 33342685 10.51 49.07 40.42 
3A 
3A vi E.coli:human 20:80 
E.coli probe eluate 
E.coli 1.5µg 42189483 6.24 61.93 31.83 
Probe amount refers to the amount of DNA used at the start of probe synthesis. Where an amount of sample is listed this is the total amount of DNA added to the hybridisation 
reaction. Read count is the number of reads obtained per single lane of paired-end Illumina GA sequencing. The proportion of the reads mapping to E.coli and human genomes are 
listed. The ‘Other’ category includes all reads that do not map to either the E.coli or human genomes and will include adapter dimers.  
 
Table 2. Genome Coverage Statistics for the E.coli Genome Pre- and Post- solution-based Pulldown 
Experiment Sample ID Sample Name Probe Average Depth Maximum Depth 
1A i E.coli:human 50:50 prepulldown ~ 63 136 
1A ii E.coli:human 25:75 prepulldown ~ 65 140 
1A iii E.coli:human 10:90 prepulldown ~ 31 78 
1A iv E.coli:human 50:50  E.coli 1.5µg 221 656 
1A v E.coli:human 25:75  E.coli 1.5µg 166 512 
1A 
1A vi E.coli:human 10:90  E.coli 1.5µg 170 501 
1B i E.coli:human 20:80 prepulldown ~ 41 94 
1B ii E.coli:human 20:80 800ng E.coli 3µg 555 1565 
1B iii E.coli:human 20:80 1600ng E.coli 3µg 669 1912 
  ~   
1B iv E.coli:human 20:80 prepulldown E.coli 1.5µg 126 288 
1B 
1B v E.coli:human 20:80 800ng E.coli 1.5µg 1267 4398 
Average depth refers to the mean number of Illumina GA sequencing reads that can be mapped to each position across the genome and the maximum depth refers to the greatest 
number of reads mapped to a single location in the genome. Probe amount refers to the amount of DNA used at the start of probe synthesis. Where an amount of sample is listed this is 
the total amount of DNA added to the hybridisation reaction. 
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Fig. (1). GC content and genome coverage distribution of E.coli samples pre- and post- solution-based pulldown. A) The percentage of 
mapped sequencing reads distributed by their GC content for; 1A i - E.coli:human 50:50 prepulldown, 1A ii - E.coli:human 25:75 
prepulldown, 1A iii - E.coli:human 10:90 prepulldown, 1A iv - E.coli:human 50:50, 1A v - E.coli:human 25:75, 1A vi - E.coli:human 10:90. 
The red line shows the theoretical value for the reference genome. B) The percentage of mapped sequencing reads distributed by their GC 
content for; 1B i - E.coli:human 20:80 prepulldown, 1B ii - E.coli:human 20:80 800ng 3µg probe, 1B iii - E.coli:human 20:80 1600ng 3µg 
probe, 1B iv - E.coli:human 20:80 prepulldown, 1B v - E.coli:human 80:20 800ng 1.5µg probe. The red line shows the theoretical normalised 
read depth across the E.coli genome. The sample curves show how much coverage is above and below the average coverage level. The further 
the sample curve is away from the theoretical line, the more biased the coverage. C) Genome coverage distribution plots for; 1A i - 
E.coli:human 50:50 prepulldown, 1A ii - E.coli:human 25:75 prepulldown, 1A iii - E.coli:human 10:90 prepulldown, 1A iv - E.coli:human 
50:50, 1A v - E.coli:human 25:75, 1A vi - E.coli:human 10:90. The red line shows the theoretical normalised read depth across the E.coli 
genome. The sample curves show how much coverage is above and below the average coverage level. The further the sample curve is away 
from the theoretical line, the more biased the coverage. D) Genome coverage distribution plots for; 1B i - E.coli:human 20:80 prepulldown, 
1B ii - E.coli:human 20:80 800ng 3µg probe, 1B iii - E.coli:human 20:80 1600ng 3µg probe, 1B iv - E.coli:human 20:80 prepulldown, 1B v - 
E.coli:human 80:20 800ng 1.5µg probe. Commentary as in part C. 
 
DNA. The conditions evaluated were 1600ng or 800ng of 
library for enrichment and 1.5µg or 3µg starting DNA for 
probe synthesis. There was little difference between the 
conditions under investigation in terms of enrichment or GC 
content (Fig. 1B and Table 1, 1B). The increase in coverage 
depth after enrichment was similar for the different 
conditions and the evenness of coverage was also similar 
(Fig. 1D and Table 2, 1B). 800ng of input DNA and 1.5µg of 
probe (initial amount for probe synthesis) were chosen for 
further experiments. During the development of this 
technique, three different biotinylation techniques were 
trialled for the synthesis of the probe molecules and it was 
found that they all provided similar results in terms of 
enrichment and sequencing statistics (see Supplementary 
Data Files 1 - 5).  
P.falciparum 
 The Plasmodium genome has been a strong research 
focus of the Wellcome Trust Sanger Institute through its 
involvement in the sequencing of the reference strain 3D7, 
and subsequent genomic diversity studies in laboratory  
and field isolates (Sanger Institute Malarial Programme 
www.sanger.ac.uk/malaria) because of the high disease 
burden inflicted by malaria. Plasmodium was predicted to be 
a more challenging organism for solution-based capture due 
to its larger genome (22.8Mb) and high content of AT bases 
A  B 
C  D 
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(80.6%) [1]. In this study, initial experiments were carried 
out using probes made from the P.falciparum laboratory 
strain 3D7 and these were used to enrich for the same strain 
within test mixtures of Plasmodium and human DNA (25:75 
Plasmodium:human). Different amounts of probe (1.5µg and 
3µg of starting DNA for probe synthesis) and library (500ng, 
800ng and 1600ng) were assessed to see which provided the 
best combination for enrichment (Table 3, 2A and 2B). As 
previously seen with the experiments using the E.coli probe 
and DNA, a high level of enrichment was seen with all 
samples (on average 71.3% of sequencing reads aligning to 
the Plasmodium genome after enrichment) and the best 
results were obtained with 800ng of library and 1.5µg of 
starting material used for probe synthesis (Table 3, 2A and 
2B). Despite the high levels of enrichment, a comparison of 
the GC content of the pre- and post-capture samples showed 
that the enrichment did not work well for AT-rich regions 
and the GC content of the post-enrichment samples was 
higher than the average for both the theoretical reference 
genome (19.4%) and the actual sequencing of the pre-
pulldown samples (Fig. 2A and 2B). This is likely to be 
caused by differences in the hybridisation temperature and 
efficiency of AT- and GC-rich DNA sequences [14, 15]. 
 As an initial measure to counteract this enrichment bias, 
the hybridisation temperature was lowered from 65oC to 
55oC. A lower hybridisation temperature was hypothesised 
to encourage better annealing of AT-rich sequences [14, 15]. 
However, in these experiments, the hybridisation temperature 
appeared to have little effect on the GC content of the 
enrichment and the lower hybridisation temperature  
actually reduced the overall enrichment of Plasmodium DNA  
Table 3. Enrichment Statistics for the P.falciparum Genome Pre- and Post- solution-based Pulldown 
Experiment Sample ID Sample Name Probe Strain Read Count % P.falciparum % Human % Other 
2A i 3D7:human 25:75 prepulldown ~ 37261895 14.97 52.88 32.15 
2A ii 3D7:human 25:75 800ng  3D7 1.5µg 36139494 72.44 8.22 19.34 2A 
2A iii 3D7:human 25:75 500ng  3D7 1.5µg 32434631 72.75 7.84 19.41 
2B i 3D7:human 25:75 prepulldown ~ 40553893 13.42 46.92 39.67 
2B ii 3D7:human 25:75 1600ng  3D7 1.5µg 21241885 66.41 15.90 17.68 
2B iii 3D7:human 25:75 1600ng  3D7 3µg 28703869 68.34 15.34 16.32 
2B iv 3D7:human 25:75 800ng  3D7 1.5µg 41465650 74.77 10.55 14.68 
2B 
2B vi 3D7:human 25:75 800ng  3D7 3µg 29455966 73.19 12.19 14.61 
2C i 3D7:human 30:70 prepulldown ~ 26938319 13.27 46.85 39.88 
2C ii 3D7:human 30:70 55oC hyb 3D7 1.5µg 7909731 67.95 10.29 21.75 2C 
2C iii 3D7:human 30:70 65oC hyb 3D7 1.5µg 8068594 75.64 5.90 18.46 
2D i 3D7:human 20:80 prepulldown ~ 35442819 11.85 43.56 44.59 
2D ii 3D7:human 20:80  3D7 1.5µg 44006702 74.34 10.21 15.45 
2D iii 3D7:human 20:80 1M TMAC  3D7 1.5µg 38447345 76.82 9.04 14.14 
2D iv 3D7:human 20:80 0.5M TMAC  3D7 1.5µg 44090067 75.20 10.34 14.46 
2D 
2D vi 3D7:human 20:80 0.1M TMAC  3D7 1.5µg 44302101 77.08 8.69 14.22 
2E i Dd2:human 30:70 prepulldown ~ 41578455 27.06 28.27 44.67 
2E 
2E ii Dd2:human 30:70 3D7 1.5µg 33817623 67.49 4.15 28.36 
2F i 3D7:human 20:80 prepulldown ~ 25542843 9.01 41.08 49.91 
2F 
2F ii 3D7:human 20:80 3D7, Dd2, IT and HB3 34060230 75.21 7.09 17.69 
2G i Isolate 1:human 20:80 prepulldown ~ 45566177 8.88 56.15 34.98 
2G ii Isolate 2:human 20:80 prepulldown ~ 37065625 6.41 51.93 41.66 
2G iii Isolate 1:human 20:80 mix probe 3D7, Dd2, IT and HB3 36955463 67.19 12.44 20.36 
2G 
2G iv Isolate 2:human 20:80 mix probe 3D7, Dd2, IT and HB3 18331991 65.47 14.89 19.64 
Enrichment determined by comparison of Illumina sequencing reads to P.falciparum 3D7 and human reference genomes. Probe amount refers to the amount of DNA used at the start 
of probe synthesis. Where an amount of sample is listed this is the total amount of DNA added to the hybridisation reaction. Read count is the number of reads obtained per single 
lane of Illumina GA sequencing. The proportion of the reads mapping to P.falciparum and human genomes are listed. The ‘Other’ category includes all reads that do not map to 
either the P.falciparum or human genomes and will include primer dimers. 
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from the human mix by a small amount, possibly due  
to increased non-specific binding of the human DNA  
(Fig. 2C and Table 3, 2C).  
 As an alternative method to counteract the high GC bias 
of the Plasmodium genome observed during sequencing  
after solution-based hybridisation, TMAC (tetramethyl 
Fig. (2). GC content of P.falciparum samples pre- and post- solution-based pulldown. The percentage of mapped sequencing reads 
distributed by their GC content. The red line shows the theoretical value for the 3D7 reference genome. A) 2A i - 3D7:human 25:75 
prepulldown, 2A ii - 3D7:human 25:75 800ng, 1.5µg probe, 2A iii - 3D7:human 25:75 500ng, 1.5µg probe. B) 2B i - 3D7:human 25:75 
prepulldown, 2B ii - 3D7:human 25:75 1600ng, 1.5µg probe, 2B iii - 3D7:human 25:75 1600ng, 3µg probe, 2B iv - 3D7:human 25:75 800ng, 
1.5µg probe, 2B v - 3D7:human 25:75 800ng, 3µg probe. C) 2C i - 3D7:human 30:70 prepulldown, 2C ii - 3D7:human 30:70 55oC hyb, 
1.5µg probe, 2C iii - 3D7:human 30:70 65oC hyb, 1.5µg probe. D) 2D i - 3D7:human 20:80 prepulldown, 2D ii - 3D7:human 20:80, 1.5µg 
probe, 2D iii - 3D7:human 20:80 1M TMAC, 1.5µg probe, 2D iv - 3D7:human 20:80 0.5M TMAC, 1.5µg probe, 2D v - 3D7:human 20:80 
0.1M TMAC, 1.5µg probe. E) 2E i - Dd2:human 30:70 prepulldown, 2E ii - Dd2:human 30:70, 1.5µg probe. F) 2F i - 3D7:human 20:80 
prepulldown, 2F ii - 3D7:human 20:80 mixed probe, 2G i - Isolate 1:human 20:80 prepulldown, 2G ii - Isolate 2:human 20:80 prepulldown, 
2G iii - Isolate 1:human 20:80 mixed probe, 2G iv - Isolate 2:human 20:80 mixed probe. 
A  B 
C  D 
E  F 
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ammonium chloride, Sigma-Aldrich) was added to the 
hybridisation buffer. TMAC is an additive which stabilises 
AT base pairs, causing AT-interactions to behave similarly 
to GC-interactions and therefore acting to reduce bias effects 
across the genome [16, 17]. It has previously been shown 
that in 3M TMAC an AT base pair is as thermally stable as a 
GC base pair [17]. In these experiments, between 0.1M and 
1M TMAC was added to the hybridisation buffer to increase 
the hybridisation of highly AT-rich regions of the 
Plasmodium genome. This additive had little effect on the 
amount of enrichment seen after pulldown and did not 
appear to significantly improve the hybridisation of the AT-
rich regions (Fig. 2D and Table 3, 2D). Possibly, insufficient 
TMAC was added to have a significant effect, however 
further TMAC could not be added due to the composition of 
the hybridisation buffer being such that it was impossible to 
add further TMAC to the buffer.  
 The extremely AT-rich regions of the Plasmodium 
genome are in non-coding areas of the genome and therefore 
the GC content of the exonic region (~23.7% GC) is not as 
extreme as seen for the non-coding regions (~13.5%) [1]. 
The exonic region is also the most interesting part of the 
genome as it contains all of the protein-coding information. 
A further analysis, concentrating on the enrichment of the 
coding regions after pulldown, demonstrated that the average 
and maximum coverage of the coding region were greatly 
increased after the enrichment procedure and up to 98.2% of 
the coding region was covered at 5x depth (Fig. 3, Table 4, 
2A-2D). The maximum depth of coverage was significantly 
higher after enrichment due to a lack of uniformity in 
coverage after pulldown has occurred (Fig. 3, Table 4, 2A-
2D). This is likely to be caused by the differences in 
hybridisation of GC- and AT-rich regions. Hybridisation 
temperature and TMAC addition did not significantly affect 
the amount or the eveness of coverage of the coding region 
recovered after hybridisation (Table 4, 2C and 2D). Despite 
this coverage nonuniformity it was still possible to identify 
single nucleotide polymorphisms (SNPs) at 10 x coverage at 
a similar rate pre- and post-enrichment (Table 4, 2A-2D). 
This observation would suggest that the uneven coverage 
does not affect SNP calling and that there is sufficient 
coverage of the exome after enrichment for useful analytical 
measurements to be made.  
 In order to further assess the utility of this technique, it 
was important to test other strains of P.falciparum. In a 
preliminary experiment, probes were made from 
P.falciparum laboratory strain 3D7 and these probes were 
used to selectively hybridise DNA from P.falciparum strain 
Dd2 from a mixed Plasmodium and human sample (30:70 
P.falciparum Dd2:human). The hybridisation was successful, 
but the amount of enrichment was lower (67.49% of 
sequencing reads aligning to the Plasmodium genome after 
enrichment) than was seen when both the probes and DNA 
library for enrichment were generated from the same strain 
(Table 3, 2E). This was expected because the genomes of the 
two strains are somewhat different and some regions will not 
hybridise during the enrichment process. In addition, the 
enriched DNA was aligned to the 3D7 reference genome and 
 
Fig. (3). Plot to compare coverage pre- and post-pulldown for a random exonic, intronic and intergenic region in the P falciparum 
genome [21]. Reads aligned to the region of interest are shown for A) a pre-pulldown sample and B) a post-pulldown matched sample. In 
both pre- and post-pulldown samples, coverage of >100 was observed in areas of both of the exonic regions shown. Intergenic and intronic 
regions show low or no coverage. Blue reads indicate perfect matches to the reference genome and red reads indicate the presence of non-
matched bases (less than 2 nucleotides mismatched per read). 
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some sequences specific for the Dd2 strain would not 
register as Plasmodium DNA. This manifests itself as a 
higher amount of ‘other’ DNA observed after enrichment for 
the Dd2 strain. No reference was available for the Dd2 
strain. The GC content of the enriched Dd2 DNA was similar 
to that observed when enriching a P.falciparum 3D7 genome 
(Fig. 2E). Approximately 95% of the coding region was 
covered to 5x depth in the enriched sample, and this is 
similar to the value obtained for the prepulldown sample 
(96%), indicating that little of the coding region DNA is lost 
during the hybridisation (Table 4, 2E). The average depth of 
coverage across the exome was approximately double for the 
postpulldown Dd2 strain sample (227x) compared to the 
prepulldown sample (99x) and the maximum depth of coverage 
was approximately 8x higher in the enriched sample (8007x) 
compared to the non-enriched sample (1138x). Taken 
together, these results suggest coverage non-uniformity in 
the enriched sample with some areas having extremely high 
levels of coverage. SNP calling was carried out for these 
samples using the P.falciparum 3D7 genome as a reference 
and hence many SNPs were detected both pre- (5599 SNPs) 
and post-enrichment (5158 SNPs) due to differences between 
the two strains (Table 4, 2E). 92% of the SNPs detected pre-
enrichment could also be detected in the enriched sample, 
showing good SNP detection in these samples.  
Table 4. Coding Region Coverage and SNP Detection for the P.falciparum Genome Pre- and Post- solution-based Pulldown 
Experiment Sample ID Sample 
Probe 
Strain 
Average 
Depth 
Maximum 
Depth 
% of Coding Region 
Covered at 5x 
Number of SNPs 
Detected 
2A i 3d7:human 25:75 prepulldown ~ 49 548 99.86 9 
2A ii 3d7:human 25:75 800ng 3D7 1.5µg 266 8005 95.04 7 2A 
2A iii 3d7:human 25:75 500ng 3D7 1.5µg 243 8006 73.46 10 
2B i 3D7:human 25:75 prepulldown ~ 48 479 99.48 13 
2B ii 3D7:human 25:75 1600ng  3D7 1.5µg 145 7948 90.11 12 
2B iii 3D7:human 25:75 1600ng  3D7 3µg 204 7970 93.9 12 
2B iv 3D7:human 25:75 800ng  3D7 1.5µg 317 7987 90.59 13 
2B 
2B vi 3D7:human 25:75 800ng  3D7 3µg 224 7971 70.32 12 
2C i 3d7:human 30:70 prepulldown ~ 32 482 98.85 12 
2C ii 3D7:human 30:70 55oC hyb 3D7 1.5µg 54 3623 40.97 3 2C 
2C iii 3D7:human 30:70 65oC hyb 3D7 1.5µg 63 4625 36.11 10 
2D i 3d7:human 20:80 prepulldown ~ 36 331 99.33 8 
2D ii 3d7:human 20:80 3D7 1.5µg 311 7989 97.06 10 
2D iii 3d7:human 20:80 1M TMAC 3D7 1.5µg 271 7944 95.65 10 
2D iv 3d7:human 20:80 0.5M TMAC 3D7 1.5µg 317 7981 96.86 10 
2D 
2D vi 3d7:human 20:80 0.1M TMAC 3D7 1.5µg 329 7983 98.19 9 
2E i Dd2:human 30:70 prepulldown ~ 99 1138 96.44 5599 
2E 
2E ii Dd2:human 30:70 3D7 1.5µg 227 8007 94.58 5158 
2F i 3D7:human 20:80 prepulldown ~ 19 359 98.92 9 
2F 
2F ii 3D7:human 20:80 mix probe 3D7, Dd2, 
IT and HB3 
260 8005 67.15 8 
2G i Isolate 1:human 20:80 
prepulldown 
~ 35 496 96.32 5181 
2G ii Isolate 2:human 20:80 
prepulldown 
~ 20 259 94.90 4696 
2G iii Isolate 1:human 20:80 mix probe 3D7, Dd2, 
IT and HB3 
242 8023 79.22 4097 
2G 
2G iv Isolate 2:human 20:80 mix probe 3D7, Dd2, 
IT and HB3 
120 7998 59.39 3310 
Average depth refers to the mean number of Illumina GA sequencing reads that can be mapped to each position along the genome and the maximum depth refers to the greatest 
number of reads mapped to a single location in the genome. Coding region coverage shows the percent of the coding region covered by at least 5 sequencing reads. A minimum SNP 
quality of 1 error per 1000bp was used for SNP filtering. SNPs were excluded if in telomeric, subtelomeric or non-unique regions or if present in hypervariable gene families. Probe 
amount refers to the amount of DNA used at the start of probe synthesis. 
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 To further test this technique with other Plasmodium 
strains, probes were made from a mixture of four different 
P.falciparum strains (3D7, Dd2, IT and HB3). This mixed 
probe was used to enrich for P.falciparum reference strain 
3D7 DNA from a mixture with human DNA (Plasmodium: 
human 20:80). The four strain probe mix provided as good 
an enrichment as the single strain probe mix previously  
used but the coding region showed poorer coverage after 
enrichment with the mixed probe (Table 3, 2F and Table 4, 
2F). This could possibly suggest that the DNA from the  
HB3 and IT strains was of poor quality or that these strains 
are quite divergent in exonic regions and have fewer regions 
of complimentarity with the 3D7 strain. Despite only  
67% of the coding region being covered at 5x depth after 
enrichment, compared to 99% pre-enrichment, the number of 
SNPs detected was similar before and after enrichment 
(Table 4, 2F). 
 This method was also tested using mixtures of human 
DNA and one of two P.falciparum clinical isolates. The  
two clinical samples used in this study were collected  
from clinical malaria patients in Southeast Asia and were 
cultured for a short while before DNA extraction. They are 
multiclonal in nature and contain a small amount of human 
contamination even before they were mixed with human 
DNA (20:80 P.falciparum clinical isolate:human) in these 
experiments. The enrichment of these clinical samples was 
comparable, albeit not quite as good as for the reference 
strain, with over 65% of the DNA after pulldown, using the 
four strain mixed probe, being complimentary to the 
P.falciparum 3D7 reference genome (Table 3, 2G). Similar 
to previous experiments, the AT-rich regions were  
not captured during the hybridisation and therefore the  
GC content is not very close to the theoretical value 
(approximately 35% GC, Fig. 2F). However, the coding 
region showed acceptable coverage in both samples post-
enrichment (clinical 1 – 79.22% at 5x coverage and clinical 2 
– 59.39% at 5x coverage, Table 4, 2G), although to a  
lesser degree than the pre-pulldown samples. Several  
SNPs were detected in both samples when compared to  
the 3D7 reference strain (Table 4, 2G). SNP detection was 
poorer after enrichment, with 79% (4097/5181) and 70% 
(3310/4696) (clinical sample 1 and 2 respectively) of SNPs 
being detected after pulldown (Table 4, 2G). Overall, results 
from the mixed probe experiments demonstrate that this 
probe was not very successful for enrichment and this is 
likely to be due to poor quality of DNA from the IT and HB3 
strains. Better results may have been achieved using a pure 
3D7 probe with these clinical samples, however this was not 
attempted. Using a reference strain such as 3D7 to enrich  
for clinical samples will always miss some regions of  
the genomes of the clinical isolates due to differences in  
the genomic sequences. This is a caveat of this kind of 
experiment and interesting, novel regions from the clinical 
isolate’s genome will be missed, however SNP calling 
should still be possible.  
ALTERNATIVE TECHNIQUE 
 Due to the enrichment bias observed with the 
Plasmodium genome, an alternative method of enrichment 
was investigated. In this method, probes were made from 
whole-genome human DNA and these were used to 
selectively remove the human DNA from an E.coli and 
human mixed sample. Sequencing was then carried out on 
the portion of the library that did not hybridise to the probes. 
It was reasoned that using hybridisation to human DNA 
could reduce or eliminate the contaminating human  
DNA whilst maintaining the pathogen genome without bias 
caused by the effects of different hybridisation efficiencies. 
However, when using 10µg of human probe, the amount of 
human sample DNA remaining with the E.coli DNA after 
enrichment was still significant (Table 1, 3A). This would 
suggest that the hybridisation is not efficient and that vast 
quantities of human probe would be required to successfully 
remove all traces of human DNA. In addition, the fact  
that the material used for sequencing is derived from non-
hybridised material, means that significant amount of adapter 
dimer and other contaminants were also sequenced, further 
reducing sequencing efficiency and E.coli enrichment. These 
poor results did not provide sufficient support to extend  
this protocol to the Plasmodium genome, although further 
experiments could be carried out. 
CONCLUSIONS 
 In this study a solution-based hybridisation method for 
the enrichment of pathogen DNA from samples that are 
heavily contaminated with human DNA was investigated. 
This technique may have clinical utility in isolating pathogen 
DNA from clinical samples that are heavily contaminated 
with human DNA and thus improve whole-genome 
sequencing efficiency and pathogen identification. The 
technique developed in this study uses basic molecular 
laboratory techniques and off-the-shelf reagents. In addition, 
the probes can be synthesised in-house from whole-genome 
DNA. This means that the whole process is inexpensive and 
straightforward, which makes this an attractive alternative to 
commercial enrichment protocols [2, 3, 9]. 
 The solution-based enrichment technique was successful 
for the enrichment of E.coli DNA from mixed E.coli:human 
samples, even when the initial mix contained as little as 10% 
E.coli DNA. The depth of coverage across the genome was 
significantly increased by the process, showing that a good 
level of enrichment was achieved. GC content was not 
affected by the process and the uniformity of coverage  
was good throughout the genome. This technique works 
extremely well for this small, GC-neutral genome. 
 This technique was also applied to the larger 
P.falciparum genome which is notoriously difficult to 
sequence compared to many other genomes, largely due to 
its high AT content (80.6%), particularly in non-coding 
regions (86.5%) and because of a high content of repetitive 
sequences [1]. After the enrichment procedure, a significant 
reduction in the amount of human DNA was observed. 
However, a bias was observed in the Plasmodium DNA that 
was enriched, with regions with a high AT content being 
poorly represented after hybridisation. This is likely to be 
caused by biases within the hybridisation process because 
AT-rich regions are known to display poorer hybridisation 
than GC-rich regions [14, 15]. In these experiments, 
lowering of the hybridisation temperature from 65oC to 55oC 
or inclusion of the additive TMAC did not reduce this 
hybridisation bias. The AT bias meant that the uniformity of 
Solution Pulldown of Pathogen DNA The Open Genomics Journal, 2012, Volume 5    27 
coverage across the genome was lower, with many coding 
regions of the P.falciparum genome being extremely over-
represented and some intergenic and repetitive regions 
completely absent. This biased coverage is also seen, 
although to a lesser extent, with standard next-generation 
sequencing and therefore recent population genetics studies 
focus on coding regions. In this study, considering only the 
coding region, which has a higher GC content than the rest 
of the genome, improved the coverage, with a large 
proportion of samples having >90% of their coding regions 
covered to 5x depth. In addition, SNP calling was similar 
pre- and -post-enrichment, suggesting a potential clinical 
utility for this technique. As coverage in coding regions was 
higher in the post-enrichment samples, SNP detection is 
therefore of higher confidence.  
 It is possible that RNA probes similar to those used by 
Melnikov et al., [12] may have different hybridisation 
kinetics to the DNA probes used here, resulting in better 
hybridisation to, and capture of, AT- rich sequences. Further 
investigation is required to determine which of these 
approaches is superior. 
 As an alternative approach, probes were made with 
human DNA and these were used to hybridise and remove 
human DNA from a mixed sample of human and pathogen 
DNA. It was found that even when large quantities (10µg) of 
human DNA was used for probe synthesis, there was still 
significant amounts of human contamination present with the 
bacterial (E.coli) DNA after the hybridisation-based cleanup. 
This would suggest that the hybridisation process is very 
inefficient when using the human probe, probably due to the 
large size and high complexity of the human genome. It is 
likely that the amount of human probe required for efficient 
elimination of human contamination in clinical material may 
be difficult and expensive to obtain for routine use.  
 This solution-based hybridisation technique provides a 
cost-effective, straightforward method to enrich samples for 
a genome of interest. The method was successfully applied 
to mixtures of human and E.coli DNA, with high amounts of 
evenly distributed coverage obtained throughout the E.coli 
genome. When applied to the difficult P.falciparum genome, 
an uneven coverage across the genome was obtained, which 
is likely to be caused by difficulties in hybridisation of the 
AT-rich regions of the genome. Non-uniformity of coverage 
was also observed in pre-enrichment samples but to a lesser 
extent. Despite the lack of uniformity observed in the enriched 
samples, the coding region of the P.falciparum genome showed 
high levels of coverage and SNP calling was possible and 
comparable to the non-enriched samples. The utility of this 
process could be further developed to enable the simultaneous 
hybridisation of several patient samples through indexing of 
the patient DNA or it could be used to isolate several 
different pathogens in the same capture experiment and 
therefore it may be useful for metagenomic studies. 
METHODS 
DNA 
 Male human DNA (Promega) and E.coli DNA (strain B, 
Sigma-Aldrich) were purchased from commercial suppliers. 
P. falciparum DNA was obtained from either i) long-term 
cultured parasite lines (laboratory clones 3D7, HB3, IT and 
Dd2) or ii) short-term culture parasite isolates obtained from 
patients with malaria in Cambodia. P. falciparum in vitro 
culture was performed as previously described [18]. 
Genomic DNA was extracted from infected red blood cell 
pellets using the QIAamp DNA Blood MidiKit (Qiagen) 
according to the manufacturer’s protocol. 
 Clinical samples were collected with written consent 
from adult patients or from a parent or guardian of paediatric 
patients. These samples were collected under a project with 
ethical approval obtained from the Ministry of Health in 
Cambodia. 
PROBE SYNTHESIS 
 Probes were synthesised from 1.5µg or 3µg of whole-
genome E.coli or P. falciparum DNA samples, or 10µg of 
whole-genome human DNA. The DNA was fragmented to 
approximately 150bp by adaptive focused acoustics using a 
Covaris S2 (Covaris. Inc.) with AFA tubes (Duty cycle: 20, 
Intensity: 5, Cycle burst: 200, Duration: 180). Subsequently, 
the DNA fragments were end repaired (1 hour at 20oC) and 
A-tailed (1 hour at 37oC) following the standard Illumina 
library preparation protocol and using the NEBNext DNA 
Sample Prep Reagent Set 1 (New England Biolabs). 
Intervening purification steps were by column purification 
(QIAquick or Minelute PCR Purification Kits, Qiagen). The 
DNA fragments were then enzymatically biotinylated by 
addition of 0.1mM Biotin-16-dUTP (Biotium), 100U 
terminal transferase, 1.25µM CoCl2 and 1x terminal 
transferase buffer (New England Biolabs). Incubation was 
carried out for 30mins at 37oC prior to column purification 
using the Minelute PCR Purification kit (Qiagen) and elution 
in 10µl of EB Buffer (Qiagen). 
LIBRARY SYNTHESIS 
 Libraries were synthesised from a total of 1µg of DNA 
consisting of a mixture of E.coli or P.falciparum DNA 
mixed in differing proportions with human DNA. The DNA 
was fragmented to approximately 200-300bp using the 
Covaris S2 with AFA tubes (Duty cycle: 20, Intensity: 5, 
Cycle burst: 200, Duration: 120). End repair, A-tailing and 
adapter ligation were carried out following standard Illumina 
library preparation methodology. The NEBNext DNA 
Sample Prep Reagent Set 1 (New England Biolabs) was used 
throughout and incubations were carried out for 1 hour  
at 20oC (end repair), 1 hour at 37oC (A-tailing) and for 2 
hours at 18oC (adapter ligation). Standard Illumina adapter 
sequences (forward 5'-GATCGGAAGAGCGGTTCAGCA 
GGAATGCCGAG-3’, reverse 5'-ACACTCTTTCCCTA 
CACGACGCTCTTCCGATCT-3’) were used. Column 
purification (QIAquick or Minelute PCR Purification Kits, 
Qiagen) was carried out between each stage and after the 
final column purification step the libraries were eluted in 
50µl of EB buffer (from the Qiagen kit). PCR amplification 
was carried out using 2µl Herculase II Phusion DNA 
Polymerase, 0.1mM dNTP mix and 1x Herculase Reaction 
Buffer (Stratagene) in a total volume of 100µl. 0.2µM of 
each of the standard Illumina primer sequences (forward 5'-
AATGATACGGCGACCACCGAGATCTACACTCTTTCC
CTACACGACGCTCTTCCGATCT-3’, reverse. 
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 5'-CAAGCAGAAGACGGCATACGAGATCGGTCTC 
GGCATTCCTGCTGAACCGCTCTTCCGATCT-3’) were 
used per reaction and these were purchased from Sigma-
Genosys. Amplification was achieved using the following 
cycling conditions: 98oC for 30sec followed by six cycles of 
98oC for 10sec, 65oC for 30sec, 72oC for 30sec and a final 
elongation incubation of 72oC for 5mins. After amplification, 
the libraries were purified using AMPure beads (Agencourt) 
and eluted in a total of 60µl of water (the beads were eluted 
twice with 30µl). The Agilent 2100 Bioanalyser (Agilent 
Technologies) and the associated DNA1000 kit (Agilent 
Technologies) were used to determine quality and 
concentration of the libraries. 
HYBRIDISATION 
 500ng, 800ng or 1600ng of each library (determined 
from the Agilent 2100 Bioanalyser traces) was lyophilised 
using a Concentrator Plus/Vacufuge Plus (Eppendorf) at 
room temperature. Once completely dried, the libraries were 
resuspended in 5µl of ultrapure water. 1µg of each of  
two blocking oligos (standard Illumina primer sequences, 
5’AATGATACGGCGACCACCGAGATCTACACTCTTT
CCCTACACGACGCTCTTCCGATCT3’ 
 5’CAAGCAGAAGACGGCATACGAGATCGGTCTCG
GCATTCCTGCTGAACCGCTCTTCCGATCT3’) was added 
to the library samples. Library samples were denatured at 
96oC for 5 minutes before incubation at 65oC. 40µl aliquots 
of 2x hybridisation buffer (10x SSPE (Sigma-Aldrich),  
10x Denhardt’s Solution (Sigma-Aldrich), 10mM EDTA 
(Calbiochem), 0.2% SDS (Sigma-Aldrich)) underwent a 
similar denaturation and incubation process. After incubation 
of the libraries and hybridisation buffer aliquots at 65oC for 5 
minutes, one 5µl aliquot of probe solution (half of the 
original 3µg preparation) for each library was mixed with 
5µl of water prior to incubation at 96oC for 5 minutes. The 
probes and 16µl of hybridisation buffer were then added  
to the libraries, whilst maintaining the 65oC incubation 
temperature. Incubation was then carried out for a further 24 
hours at this temperature. 
ISOLATION OF HYBRIDISED DNA 
 After incubation was complete, the samples were  
added to Dynabeads® MyOneTM Streptavidin C1 beads 
(Invitrogen) that had been pre-washed and resuspended in 
200µl of binding buffer (1M NaCl (Sigma-Aldrich), 10mM 
Tris-HCl pH7.5 (Sigma-Aldrich), 1mM EDTA (Sigma-
Aldrich)). The samples were then placed on a Nutating 
Mixer (VWR International) for 30mins to mix. The beads 
and solutions were then separated using a magnetic separator 
and the beads were washed with Wash Buffer 1 (1xSSC 
(Sigma-Aldrich), 0.1% SDS (Sigma-Aldrich)) before 
incubation at room temperature for 15 minutes. Wash buffer 
1 was then removed and three washes with Wash Buffer 2 
(0.1xSSC (Sigma-Aldrich), 0.1% SDS (Sigma-Aldrich)) 
were carried out. Wash buffer 2 was pre-warmed to 65oC and 
incubations between each step were carried out for 10 
minutes at this temperature. 50µl of 0.1M NaOH (Sigma-
Aldrich) was then added to the beads. The beads were mixed 
thoroughly before magnetic separation and collection of the 
sample eluate. The eluate was then neutralised by addition of 
an equal volume of 1M Tris-HCl pH7.5 (Sigma) before the 
samples were desalted by column purification (QIAquick 
PCR Purification Kit, Qiagen) and eluted in 36µl of EB 
buffer. The recipes for many of the buffers used in this 
protocol were obtained from Gnirke et al., (2009) Nature 
Biotechnology, 27 [9].  
SAMPLE QUANTIFICATION 
 Samples were quantified both pre- and post-hybridisation 
by qPCR using the KAPA Illumina ABI Library 
Quantification Kit (KAPA Biosciences), following the 
manufacturer’s protocol. 
SEQUENCING 
 Pre- and post-hybridisation samples were sequenced 
using an Illumina GAIIx machine and associated Illumina 
reagents. Samples were loaded at 12-14pM and a single lane 
of paired-end 76bp sequencing (except experiment 1A where 
37bp paired-end sequencing was used) was carried out for 
each sample.  
DATA ANALYSIS 
 All read mappings were carried out using the software 
package BWA and the coverage data were derived from their 
pileup analysis using the software package SAMtools [19, 
20]. Using the same mapping results, GC plots were 
calculated. The theoretical GC curves were generated from 
the genome reference using a read generated starting from 
each base in the reference and of the same length as the 
sequencing reads. 
 For P.falciparum SNP analysis, sequence reads were 
aligned to the 3D7 reference genome (version 2.1.5) using 
BWA. A list of SNPs was generated using SAMtools and 
BCFtools at default settings. A minimum SNP quality of 30 
(1 error per 1000bp) was used to filter the initial list of 
SNPs. For further analysis, the SNPs that mapped to 
telomeric, subtelomeric, non-unique regions and highly 
variable gene families were excluded. Allele calls were 
compared between samples using the R statistical package. 
To observe the distribution of coverage and potential 
location of SNPs on the whole genome, sequencing data was 
uploaded into LookSeq, a browser-based viewer for deep 
sequencing data [21]. 
ABBREVIATIONS 
E.coli = Escherichia coli  
Gb = Gigabase  
NGS = Next generation sequencing  
P.falciparum = Plasmodium falciparum 
qPCR = Quantitative polymerase chain reaction 
SNP = Single-nucleotide polymorphism 
TMAC = Tetramethyl ammonium chloride 
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